Text Size

Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00896142
First received: May 8, 2009
Last updated: November 21, 2011
Last verified: November 2011
History of Changes
  Purpose

To evaluate the impact of left ventricular (LV) lead location on LV mechanical function.


Condition
Heart Failure
Ischemic Cardiomyopathy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Optima CAD (Optimal Mechanical Evaluation)

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Pittsburgh:

Enrollment: 50
Study Start Date: October 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

18+ years of age must be patients of UPMC Cardiovascular Institute

Criteria

Inclusion Criteria

  1. Ischemic Cardiomyopathy
  2. Left ventricular ejection fraction less than 40%
  3. Clinical indication for invasive electrophysiology testing
  4. Patient is at least 18 years of age

Exclusion Criteria

  1. Unstable angina, acute myocardial infarction and/or revascularization procedure within 3 months
  2. CVA or TIA within the past 6 months
  3. Prosthetic heart valve
  4. Patient is status post heart transplant
  5. Women who are pregnant or with child -bearing potential and who are not on a reliable form of birth control. Women of child-bearing potential are routinely tested for pregnancy as part of the standard of care prior to EPS procedures being performed.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00896142

Locations
United States, Pennsylvania
UPMC Presybterian
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: David S. Schwartzman, MD University of Pittsburgh
  More Information

No publications provided

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00896142     History of Changes
Other Study ID Numbers: 0601112
Study First Received: May 8, 2009
Last Updated: November 21, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pittsburgh:
ischemic cardiomyopathy
cardiac resynchronization therapy
LV structure and function

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Failure
Ischemia
Cardiomyopathies
 Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 19, 2013